National Health Research Institutes, Taiwan: Lymphoma trials

The registry lists 11 Lymphoma studies with National Health Research Institutes, Taiwan as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 7No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase I/II Study of Diffuse Large B-cell LymphomaNot yet recruitingNCT04856137Phase 1/2
• Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell LymphomasTerminatedNCT05105412Phase 1/2
• First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCLStatus unknownNCT02388581Phase 2
• Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
• a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
• Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
• A Phase II Study of Nasal NK/T-cell LymphomaCompletedNCT00292695Phase 2
• A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant LymphomaStatus unknownNCT00266370
• A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus CarriersCompletedNCT00262210Phase 2
• Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALTomaCompletedNCT00201422Not applicable
• A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface AntigenCompletedNCT00201318Phase 2